You are here

  • Home
  • Archive
  • Volume 80, Issue Suppl 1
  • OP0230 EFFICACY AND SAFETY OF GUSELKUMAB IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS WHO DEMONSTRATED INADEQUATE RESPONSE TO TUMOR NECROSIS FACTOR INHIBITION: WEEK 24 RESULTS OF A PHASE 3B, RANDOMIZED, CONTROLLED STUDY

Article metrics

Article menu

Download PDFPDF

Scientific Abstracts
Oral Presentations
Psoriatic arthritis - treatment
OP0230 EFFICACY AND SAFETY OF GUSELKUMAB IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS WHO DEMONSTRATED INADEQUATE RESPONSE TO TUMOR NECROSIS FACTOR INHIBITION: WEEK 24 RESULTS OF A PHASE 3B, RANDOMIZED, CONTROLLED STUDY
Free

 

Online download statistics by month:

Online download statistics by month: May 2021 to October 2024

AbstractFullPdf
May 202110012
Jun 2021101051
Jul 202115046
Aug 20219047
Sep 202114047
Oct 2021217057
Nov 2021371098
Dec 2021204039
Jan 2022151025
Feb 2022104018
Mar 202274023
Apr 20224204
May 202260015
Jun 20225909
Jul 20224403
Aug 20223905
Sep 202261011
Oct 20225508
Nov 20224006
Dec 20223704
Jan 202346010
Feb 20233703
Mar 20233502
Apr 20232603
May 20231606
Jun 20234006
Jul 202332013
Aug 202323010
Sep 20233109
Oct 20232005
Nov 20234203
Dec 20233901
Jan 20244106
Feb 20243209
Mar 20243807
Apr 202430010
May 20241002
Jun 20241702
Jul 20243407
Aug 20242906
Sep 20241606
Oct 20241501
Total23560655